24.04.2024 • News

KBR Wins Contract from SABIC Fujian Petrochemicals

US-based multinational contractor KBR has been awarded a contract by SABIC Fujian Petrochemicals to license its phenol technology in China.

Under the terms of the contract, KBR will provide technology licensing and proprietary engineering design for a 250 kt/a phenol plant at SABIC Fujian Petrochemical’s complex in China’s Fujian province. The final investment decision for this estimated $6.4 billion project was announced in January 2024 with expected completion in 2026. According to KBR, its phenol technology offers reduced energy consumption and improved yields.

“We are excited to offer our industry leading phenol technology to SABIC Fujian for this ambitious project in China,” said Jay Ibrahim, president of KBR Sustainable Technology Solutions. “KBR’s market-leading phenol technology increases our customers’ competitive advantage and advances their sustainability objectives through superior efficiency, reliability, wastewater recovery and performance,” Ibrahim added.

© KBR
© KBR

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.